Akademska digitalna zbirka SLovenije - logo
E-viri
Recenzirano Odprti dostop
  • The Now and Beyond of Tumor...
    Nandakumar, Vijayalakshmi; Mills, John R

    Clinical chemistry (Baltimore, Md.), 02/2019, Letnik: 65, Številka: 2
    Journal Article

    Since their approval in 2014, immune checkpoint inhibitors (ICIs)2 have transformed cancer care. ...the Food and Drug Administration recently designated the bTMB assay as a "breakthrough device," prioritizing the test for review. ...the successes of tissue-based TMB may not be transferrable to bTMB.